tiprankstipranks
Trending News
More News >
Pharma Foods International Co., Ltd. (JP:2929)
:2929
Japanese Market
Advertisement

Pharma Foods International Co., Ltd. (2929) Stock Statistics & Valuation Metrics

Compare
1 Followers

Total Valuation

Pharma Foods International Co., Ltd. has a market cap or net worth of ¥24.19B. The enterprise value is ¥29.08B.
Market Cap¥24.19B
Enterprise Value¥29.08B

Share Statistics

Pharma Foods International Co., Ltd. has 29,079,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,079,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Pharma Foods International Co., Ltd.’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 11.20%.
Return on Equity (ROE)0.28
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)11.20%
Return on Capital Employed (ROCE)0.38
Revenue Per Employee96.80M
Profits Per Employee7.84M
Employee Count642
Asset Turnover1.70
Inventory Turnover1.99

Valuation Ratios

The current PE Ratio of Pharma Foods International Co., Ltd. is 64.4. Pharma Foods International Co., Ltd.’s PEG ratio is ―.
PE Ratio64.4
PS Ratio
PB Ratio
Price to Fair Value2.70
Price to FCF
Price to Operating Cash Flow1.54K
PEG Ratio

Income Statement

In the last 12 months, Pharma Foods International Co., Ltd. had revenue of 62.15B and earned 3.21B in profits. Earnings per share was 112.69.
Revenue62.15B
Gross Profit48.75B
Operating Income5.11B
Pretax Income5.03B
Net Income3.21B
EBITDA6.00B
Earnings Per Share (EPS)112.69

Cash Flow

In the last 12 months, operating cash flow was -982.00M and capital expenditures -624.00M, giving a free cash flow of -1.61B billion.
Operating Cash Flow-982.00M
Free Cash Flow-1.61B
Free Cash Flow per Share-55.23

Dividends & Yields

Pharma Foods International Co., Ltd. pays an annual dividend of ¥12.5, resulting in a dividend yield of 3.03%
Dividend Per Share¥12.5
Dividend Yield3.03%
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.93
52-Week Price Change-5.52%
50-Day Moving Average908.55
200-Day Moving Average906.16
Relative Strength Index (RSI)32.80
Average Volume (3m)277.53K

Important Dates

Pharma Foods International Co., Ltd. upcoming earnings date is Dec 3, 2025, TBA (Confirmed).
Last Earnings DateSep 11, 2025
Next Earnings DateDec 3, 2025
Ex-Dividend DateJul 30, 2025

Financial Position

Pharma Foods International Co., Ltd. as a current ratio of 1.18, with Debt / Equity ratio of 103.29%
Current Ratio1.18
Quick Ratio0.89
Debt to Market Cap0.54
Net Debt to EBITDA0.20
Interest Coverage Ratio82.47

Taxes

In the past 12 months, Pharma Foods International Co., Ltd. has paid 1.83B in taxes.
Income Tax1.83B
Effective Tax Rate0.36

Enterprise Valuation

Pharma Foods International Co., Ltd. EV to EBITDA ratio is 5.42, with an EV/FCF ratio of 7.21.
EV to Sales0.52
EV to EBITDA5.42
EV to Free Cash Flow7.21
EV to Operating Cash Flow5.93

Balance Sheet

Pharma Foods International Co., Ltd. has ¥10.35B in cash and marketable securities with ¥13.27B in debt, giving a net cash position of -¥2.92B billion.
Cash & Marketable Securities¥10.35B
Total Debt¥13.27B
Net Cash-¥2.92B
Net Cash Per Share-¥100.52
Tangible Book Value Per Share¥401.11

Margins

Gross margin is 79.37%, with operating margin of 8.23%, and net profit margin of 5.16%.
Gross Margin79.37%
Operating Margin8.23%
Pretax Margin8.10%
Net Profit Margin5.16%
EBITDA Margin9.66%
EBIT Margin8.20%

Analyst Forecast

The average price target for Pharma Foods International Co., Ltd. is ¥916.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥916.00
Price Target Upside9.70% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast5.01%
EPS Growth Forecast-87.90%

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis